Debt to Equity Ratio Chart

View Debt to Equity Ratio for PXMBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 0.0112
December 31, 2025 0.0321
September 30, 2025 0.0251
June 30, 2025 0.0419
March 31, 2025 0.0346
December 31, 2024 0.1218
September 30, 2024 0.1176
June 30, 2024 0.0914
March 31, 2024 0.1264
December 31, 2023 0.1107
September 30, 2023 0.1508
June 30, 2023 0.144
March 31, 2023 0.1462
December 31, 2022 0.1487
September 30, 2022 0.1594
June 30, 2022 0.1146
March 31, 2022 0.1316
December 31, 2021 0.1364
Date Value
September 30, 2021 0.649
June 30, 2021 0.6423
March 31, 2021 0.5567
December 31, 2020 4.429
September 30, 2020 2.352
June 30, 2020 1.743
March 31, 2020 1.186
December 31, 2019 1.109
September 30, 2019 1.088
June 30, 2019 0.9492
March 31, 2019 0.761
December 31, 2018 0.5031
September 30, 2018 0.2852
June 30, 2018 0.1876
March 31, 2018 0.1386
December 31, 2017 0.0842
September 30, 2017 0.0891
June 30, 2017 0.0669

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Getinge AB 0.3547
Xvivo Perfusion AB 0.0566
Abbott Laboratories 0.654
AngioDynamics, Inc. 0.0657
Alphatec Holdings, Inc. 33.03